Notice ID: dfbaa2b6d1c04cc8865415be876e6138Award NoticeAwarded
Development of a VesiVax� HIV Vaccine Formulation
Awarded on July 1, 2021. The description is published on SAM.gov: Full description on SAM.gov.
Awarded tounder 75N93021C00027 (source: SAM.gov award notice)• $2.3M
Overview
- Posted
- July 2, 2021
- Notice type
- Award Notice
- Set-aside
- Total Small Business Set-Aside (FAR 19.5)
- NAICS
- NAICS 54171 Research and Development in the Physical, Engineering, and Life Sciences (reported as 541710)
Notice details
- Place of performance
- Rancho Dominguez, CA, 90220
- Last updated
- Dec 4, 2025
- Award date
- Jul 1, 2021
- Award amount (SAM.gov award notice)
- $2.3M
Identifiers
- Solicitation number
- PHS2021-1
- Notice ID
- dfbaa2b6d1c04cc8865415be876e6138
- Award number (PIID)
- 75N93021C00027
Description
No description in the SAM.gov data feed for this notice.
Award Overview
Award Number
75N93021C00027
Award Amount (SAM.gov award notice)
$2.3M
Award Date
Jul 1, 2021
Awardee
Awardee UEI
R1JMHFESEKD5
Original Solicitation
Notice ID: dfbaa2b6d1c04cc8865415be876e6138
Posted Date: Jul 2, 2021
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- $2.0MSigned Jun 2, 2026
- $599.9KSigned Apr 10, 2025
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
PHS2021-1- Awarded
This opportunity has been awarded.
- 3×AwardedCurrentJul 2, 2021
Development of a VesiVax� HIV Vaccine Formulation
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
PHS2021-1
Archive Date
Jul 16, 2021
Office Address
BETHESDA, MD, 20892